Evidence map›Paper›PMID 42411566›Full record

ArticlePediatric pulmonology2026

Early Structural Lung Changes in Primary Ciliary Dyskinesia (PCD).

Phil Robinson, Megumi Yokote

Abstract read
In one paragraph

Article in Pediatric pulmonology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Phil RobinsonDepartments of Respiratory and Sleep Medicine, Royal Children's Hospital, Parkville, Australia.ORCID https://orcid.org/0000-0001-6129-9075
Megumi YokoteDepartment of Paediatrics, University of Melbourne, Parkville, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPrimary Ciliary Dyskinesia (PCD) is an inherited disorder commonly presenting as an autosomal recessive condition causing dysfunction of muco-ciliary clearance, which can lead to bronchiectasis. As newborn screening is not available for PCD, diagnosis is frequently delayed, often resulting in a degree of structural lung disease being detectable at or soon after diagnosis. Once the diagnosis is established, initiation of therapies including airway clearance aim to prevent or retard any progression to irreversible structural damage.

objectivesWe aimed to investigate the degree of structural changes evident in early life in PCD by examining chest CT scans in a cross-sectional study in children with PCD aged 3 years of age.

methods15 young children with proven PCD (young cwPCD) had surveillance chest CT scanning when clinically stable. The presence of bronchial wall thickening, bronchiectasis, collapse/consolidation and air trapping was described in each lobe separately.

resultsBronchial wall thickening was seen in 50% of all lobes. Bronchiectasis was seen in 38% of lobes, collapse/consolidation in 32% of lobes and air trapping in 20% of lobes. Bronchial wall thickening was seen in 23% of upper lobes, 46% of middle lobes and 80% of lower lobes. Bronchiectasis was seen in 13% of upper lobes and 37% of middle lobes (including lingula) and 63% of lower lobes.

conclusionThis cross-sectional study of early structural lung disease in PCD suggests that structural changes in PCD are present from early in life and highlights the importance of early diagnosis of PCD and the need to identify effective interventive therapy.

Indexed as

BronchiectasisKartagener SyndromeLungChild, PreschoolCross-Sectional StudiesFemaleHumansMaleTomography, X-Ray ComputedbronchiectasisHRCTPCDprimary ciliary dyskinesiaradiologysurveillance

Identifiers

PMID42411566
PMCPMC13339125

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.